China-based JV Formed and 3Dicom trial at Macau Hospital
Filed with ASX · · 3 pages · English
• Singular Health Group, has entered a 50/50 JV in Macau with a strategic investor. • JV to investigate market potential for Scan to Surgery® to the East Asian market. • Local websites have been created for Singular Health & 3Dicom in China. • Singular Health to contribute up to A$125,000 matched funding to the JV to establish a Macau office and sales team. 24 February 2022 –Singular Health Group
Singular Health Group Ltd on 6ix
Earlier from Singular Health
- IMCRC Activate - CSIRO - 3D surface scan visualisation
- Agreement signed to Build Custom Stoma Seals
- Collaborative Medical VR and 3D release align to Metaverse
- GeoVR JV to commercialise 3D & Virtual Reality software
- SHG: CSIRO Collaboration for AI-based Tool
Later from Singular Health
- SHG: & CSIRO AI Tool to Optimise Cranial Implant Procedures
- AE Commissions Medical Manufacturing Facility
- Singular Health Announces Planned Divestment of GeoVR Asset
- SHG Secures Convertible Note Investment
- SHG signs Research Agreement with AOWA and ECU
Follow Singular Health into a list and get an email when it puts out news.
Follow Singular Health